Image

Global Hemostats Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), – Industry Trends and Forecast to 2029

Hemostats Market

Market Analysis and Size

Blood loss occurs during surgery as a result of blood vessel disruption. To avoid excessive blood loss, it is critical to coagulate the blood. Hemostasis refers to the formation of blood clots at the site of injury. Haemostats are surgical tools used to control the patient's bleeding during surgery. These devices aid in the formation of temporary blood clots in order to control bleeding. It is critical, however, that the use of these tools be localised and strictly regulated.

Data Bridge Market Research analyses that the hemostats market is expected to reach the value of USD 4.65 billion by the year 2029, at a CAGR of 6.85% during the forecast period. The hemostats market is being driven by an increase in the number of surgical procedures.

Market Definition

A haemostat is a surgical tool used to control blood loss or stop bleeding during major surgery. Essentially, it is used in the early stages of surgery for an initial incision that closes blood vessels until they are ligated. It includes a variety of instruments such as needle holders, pivots, clamps, and clamps.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).

Hemostats Market Dynamics

Drivers

  • The rise in the surgical procedures

Increasing the number of surgical procedures is a critical factor driving market growth, as is an increase in the number of regulatory approvals, an increase in the incidence of sports-related injuries and spinal ailments, and an increase in the focus on effective blood loss management in patients during surgeries, among other factors driving the hemostats market.

The increase in the research and development activities and growing awareness

Rising R&D activities in the market, an increase in the number of hospitals & surgical centres, and an increase in emerging markets will all create new opportunities for the hemostats market during the forecasted period.

  • Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the hemostats market.

Restraints/Challenges

The scarcity of skilled professionals and trained expertise will be a major impediment to the growth of the hemostats market. Medication costs will also slow the market's growth rate. Inadequate reimbursement policies will also limit the scope of growth.

This hemostats market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hemostats market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Hemostats Market

With the World Health Organization officially declaring the COVID-19 outbreak a pandemic, a coalition of established pharmaceutical and biopharmaceutical companies, as well as small startups, has stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. The COVID-19 outbreak has had a significant impact on the availability of hospital resources around the world. This has primarily been addressed by drastically reducing inpatient and outpatient services for other diseases, as well as implementing infection prevention and control measures. With the pandemic affecting countries all over the world, the number of surgical procedures has plummeted precipitously.

Global Hemostats Market Scope

The hemostats market is segmented on the basis product type, formulation, application, indication and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product type                                                                      

  • Combination
  • Oxidized regenerated cellulose based
  • Gelatine based
  • Collagen based haemostat

On the basis of product type, the hemostats market is segmented into thrombin based, combination, oxidized regenerated cellulose based, gelatin based and collagen based hemostat.

Formulation

  • Matrix and gel hemostats
  • Sheet and pad hemostats
  • Sponge hemostats
  • Powder hemostats

Based on formulation, the hemostats market is segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats and powder hemostats.

Application

  • Orthopaedic
  • General surgery
  • Neurological surgery
  • Cardiovascular surgery
  • Reconstructive surgery
  • Gynaecological surgery

Based on application, the hemostats market is segmented into orthopedic, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery and gynecological surgery.

Indication

  • Closure
  • Surgery

Based on indication, the hemostats market is segmented into wound closure and surgery.

End User

  • Ambulatory centers
  • Hospitals
  • Clinics
  • Community healthcare
  • Others

The hemostats market is also segmented on the basis of end-user into hospitals, clinics, ambulatory centers, community healthcare and others.

Hemostats Market Regional Analysis/Insights

The hemostats market is analysed and market size insights and trends are provided by country, product type, formulation, application, indication and end-user as referenced above.

The countries covered in the hemostats market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominates the hemostats market due to an increase in the number of surgeries performed in the region, as well as the development of technologically advanced products for achieving blood control during trauma-related procedures.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.    

Healthcare Infrastructure growth Installed base and New Technology Penetration

The hemostats market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hemostats market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hemostats market. The data is available for historic period 2010-2020.

Competitive Landscape and Hemostats Market Share Analysis

The hemostats market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hemostats market.

Some of the major players operating in the hemostats market are

  • CR Bard, Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Baxter International, Inc. (US)
  • Integra LifeSciences (US)
  • Marine Polymer Technologies, Inc. (US)
  • Teleflex (US)
  • Ethicon, Inc. (US)
  • Pfizer, Inc. (US)
  • Z-Medica LLC (US)
  • Gelita Medical GmbH (Germany)
  • Anika Therapeutics, Inc. (US)
  • Stryker (US)
  • Integra Lifesciences Corporation(US).

Research Methodology: Global Hemostats Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLE :

TABLE 1 HEALTHCARE EXPENDITURES OF VARIOUS COUNTRIES TABLE 2 ABSORBABLE HEMOSTATIC AGENTS APPROVED THROUGH PMA OR NDA* TABLE 3 GLOBAL HEMOSTATS MARKET, BY PRODUCT TYPE, BY REGION 2015– 2024 (USD MILLION) TABLE 4 GLOBAL HEMOSTATS MARKET, BY TYPE, 2015 – 2024(USD MILLION) TABLE 5 GLOBAL HEMOSTATS MARKET, THROMBIN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 6 GLOBAL HEMOSTATS MARKET, COMBINATION AGENT, BY REGION 2015– 2024 (USD MILLION) TABLE 7 GLOBAL HEMOSTATS MARKET, OXIDIZED REGENERATED CELLULOSE BASED, BY REGION, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL HEMOSTATS MARKET, GELATIN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 9 GLOBAL HEMOSTATS MARKET, COLLAGEN BASED, BY REGION 2015– 2024 (USD MILLION) TABLE 10 GLOBAL HEMOSTATS APPLICATION MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 11 WOUND CLOSURE, BY APPLICATION, BY REGION, 2015 – 2024 (USD MILLION) TABLE 12 SURGICAL HEMOSTATS, BY APPLICATION, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL HEMOSTATS MARKET, DIRECT TENDERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 15 GLOBAL HEMOSTATS MARKET, RETAIL, BY REGION, 2015 – 2024 (USD MILLION) TABLE 16 GLOBAL HEMOSTATS MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 17 GLOBAL HEMOSTATS MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION) TABLE 18 GLOBAL HEMOSTATS MARKET, AMBULATORY CENTERS, BY REGION 2015– 2024 (USD MILLION) TABLE 19 GLOBAL HEMOSTATS MARKET, COMMUNITY HEALTHCARE, BY REGION 2015– 2024 (USD MILLION) TABLE 20 GLOBAL HEMOSTATS MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION) TABLE 21 GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 22 NORTH AMERICA HEMOSTATSMARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 23 NORTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 27 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE ,2015 – 2024 (USD MILLION) TABLE 28 U.S. HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 29 U.S.HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 30 U.S. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 31 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 32 CANADA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 33 CANADA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 34 CANADA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 35 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 36 MEXICO HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 37 MEXICO HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 38 MEXICO HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 39 EUROPE HEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 EUROPEHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 41 EUROPE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 42 EUROPE HEMOSTATS MARKET, BY END USER,2015 – 2024 (USD MILLION) TABLE 43 EUROPE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 44 GERMANYHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 45 GERMANY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 46 GERMANY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 47 GERMANY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 48 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 49 FRANCE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 50 FRANCE HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 51 FRANCE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 52 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 53 U.K. HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 54 U.K. HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 55 U.K. HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 56 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 57 ITALY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 58 ITALY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 59 ITALY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 60 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 61 SPAIN HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 62 SPAIN HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 63 SPAIN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 64 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 65 RUSSIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 66 RUSSIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 67 RUSSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 68 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 69 TURKEY HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 70 TURKEY HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 71 TURKEY HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 72 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 73 BELGIUM HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 74 BELGIUM HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 75 BELGIUM HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 76 NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 77 NETHERLANDS HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 78 NETHERLANDS HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 79 NETHERLANDS HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 80 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 81 SWITZERLAND HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 82 SWITZERLAND HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 83 SWITZERLAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 84 REST OF EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 85 APAC HEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 86 APAC HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 87 APAC HEMOSTATS MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 88 APAC HEMOSTATS MARKET, BY END USER,2015 – 2024 (USD MILLION) TABLE 89 APAC HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 90 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 91 JAPAN HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 92 JAPAN HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 93 JAPAN HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 94 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 95 CHINA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 96 CHINA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 97 CHINA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 98 SOUTH KOREAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 99 SOUTH KOREA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 100 SOUTH KOREA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 101 SOUTH KOREA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 102 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE,2015 – 2024(USD MILLION) TABLE 103 INDIA HEMOSTATS MARKET, BY APPLICATION,2015 – 2024 (USD MILLION) TABLE 104 INDIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 105 INDIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 106 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 107 AUSTRALIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 108 AUSTRALIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 109 AUSTRALIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 110 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 111 SINGAPORE HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 112 SINGAPORE HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 113 SINGAPORE HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 114 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 115 THAILAND HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 116 THAILAND HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 117 THAILAND HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 118 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 119 MALAYSIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 120 MALAYSIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 121 MALAYSIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 122 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 123 INDONESIA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 124 INDONESIA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 125 INDONESIA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 126 PHILIPPINES HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 127 PHILIPPINES HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 128 PHILIPPINES HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 129 PHILIPPINES HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 130 REST OF APACHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION) TABLE 131 SOUTH AMERICAHEMOSTATS S MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 132 SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 133 SOUTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 134 SOUTH AMERICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 135 SOUTH AMERICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 136 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 137 BRAZIL HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 138 BRAZIL HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 139 BRAZIL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 140 REST OF SOUTH AMERICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 141 MEA HEMOSTATS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 142 MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 143 MEA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 144 MEA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 145 MEA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 146 SOUTH AFRICAHEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 147 SOUTH AFRICA HEMOSTATS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 148 SOUTH AFRICA HEMOSTATS MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 149 SOUTH AFRICA HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 150 REST OF MEA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The future market value for hemostats Market is expected USD 4.65 billion by 2029.
The Hemostats Market is to grow at a CAGR of 6.85% during the forecast by 2029.
On the basis of application, the Hemostats Market is segmented into Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery.
The major players operating in the Hemostats Market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).